ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Global X Genomics & Biotechnology ETF
63.58
-0.0723
-0.11%
成交量:
3.35萬
成交額:
213.00萬
市值:
9,566.97萬
市盈率:
- -
高:
64.90
開:
64.15
低:
62.76
收:
63.65
52周最高:
68.00
52周最低:
36.76
股本:
150.47萬
流通股本:
150.47萬
量比:
0.80
換手率:
2.22%
股息:
0.65
股息率:
1.02%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
丹納赫(DHR)旗下兩子公司聯合推出Cas9 mRNA解決方案 賦能基因編輯研發加速落地
金吾财讯
·
昨天
Illumina Inc(ILMN)股票9月15日盤中上漲7.40%:關鍵驅動因素揭曉
TradingKey中文
·
昨天
Guardant Health與Evernorth旗下Evicore達成協議,Shield血液檢測自2027年1月1日起納入結直腸癌篩查覆蓋範圍
美股速递
·
09/15
阿斯利康股價盤後跌超2%,因其三期臨床試驗結果令人失望。
智通财经
·
09/12
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/hant/stock/GNOM"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"GNOM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","market":"US","secType":"STK","nameCN":"Global X Genomics & Biotechnology ETF","latestPrice":63.58,"timestamp":1789588800000,"preClose":63.6523,"halted":0,"volume":33460,"delay":0,"changeRate":-0.0011358584057449374,"floatShares":1504713,"shares":1504713,"eps":0,"marketStatus":"盤前交易","change":-0.0723,"latestTime":"09-17 09:12:39 EDT","open":64.15,"high":64.9,"low":62.76,"amount":2129992.3302,"amplitude":0.03362,"askPrice":70.12,"askSize":800,"bidPrice":61.6,"bidSize":800,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789651800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":63.58,"sharesOutstanding":1094672,"nav":63.64,"aum":95751293.13,"dividendRate":0.010198,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":63.58,"preClose":63.58,"latestTime":"19:30 EDT","volume":50,"amount":3163.1,"timestamp":1789601405431,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.7954885850056719,"impliedVol":0.2828,"impliedVolPercentile":0.724},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GNOM\",,,,,undefined,":{"symbol":"GNOM","floatShares":1504713,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7954885850056719,"shares":1504713,"dividePrice":0.6484,"high":64.9,"amplitude":0.03362,"preClose":63.6523,"low":62.76,"week52Low":36.755,"pbRate":"--","week52High":68,"institutionHeld":0,"latestPrice":63.58,"eps":0,"divideRate":0.010198,"volume":33460,"delay":0,"ttmEps":0,"open":64.15,"prevYearClose":45.4562,"prevWeekClose":62.2188,"prevMonthClose":64.4209,"prevQuarterClose":56.834,"fiveDayClose":62.7532,"twentyDayClose":58.5093,"sixtyDayClose":51.76},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GNOM\",params:#limit:5,,,undefined,":[{"date":"2026-06-29","symbol":"GNOM","amount":0.057885,"announcedDate":"2026-06-26","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-29","defaultRemindTime":1782739800000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-07-07","payableDate":"2026-06-29","currency":"USD","dateTimestamp":1782705600000,"payDate":"2026-07-07"},{"date":"2025-12-30","symbol":"GNOM","amount":0.591211,"announcedDate":"2025-12-29","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-30","defaultRemindTime":1767105000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-07","payableDate":"2025-12-30","currency":"USD","dateTimestamp":1767070800000,"payDate":"2026-01-07"},{"market":"US","date":"2025-09-02","symbol":"GNOM","defaultRemindTime":1756819800000,"type":"split","dateTimestamp":1756785600000,"forFactor":4,"toFactor":1,"ratio":4},{"date":"2025-06-27","symbol":"GNOM","amount":0.00828,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-27","defaultRemindTime":1751031000000,"name":"Global X Genomics & Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-07","payableDate":"2025-06-27","currency":"USD","dateTimestamp":1750996800000,"payDate":"2025-07-07"},{"market":"US","date":"2021-12-30","symbol":"GNOM","amount":0.006507,"defaultRemindTime":1640874600000,"name":"Global X Genomics & Biotechnology ETF","recordDate":"2022-01-07","payableDate":"2021-12-31","currency":"USD","type":"dividend","dateTimestamp":1640840400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GNOM\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-08","value":0.032402,"currency":"USD"},{"executeDate":"2021-12-30","recordDate":"2021-12-31","paymentDate":"2022-01-07","value":0.006507,"currency":"USD"},{"executeDate":"2025-06-27","recordDate":"2025-06-27","paymentDate":"2025-07-07","value":0.00828,"currency":"USD"},{"executeDate":"2025-12-30","recordDate":"2025-12-30","paymentDate":"2026-01-07","value":0.591211,"currency":"USD"},{"executeDate":"2026-06-29","recordDate":"2026-06-29","paymentDate":"2026-07-07","value":0.057885,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GNOM\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GNOM\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667985488","title":"丹納赫(DHR)旗下兩子公司聯合推出Cas9 mRNA解決方案 賦能基因編輯研發加速落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2667985488","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667985488?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 20:57","pubTimestamp":1789563457,"startTime":"0","endTime":"0","summary":"金吾财讯 | 丹纳赫 旗下两家子公司——集成DNA技术公司与Aldevron宣布推出联合研发的科研级S.p. Cas9 mRNA解决方案,涵盖野生型及SpyFi高保真两种形式,旨在加速CRISPR基因编辑项目从早期研究向符合CGMP标准的临床开发转型。该联合方案结合了IDT在CRISPR基因工程与设计方面的专业知识,以及Aldevron在mRNA领域的规模化生产能力。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/ZmFlOWFhNTNlYzgzMTc4NTEyNzIzMzYzNzY2.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZmFlOWFhNTNlYzgzMTc4NTEyNzIzMzYzNzY2.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306117","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1366333091.USD","LU1923622614.USD","BK4534","LU0708995401.HKD","XT","LU0114720955.EUR","SYNB","TARK","CRSP","IE000M9KFDE8.USD","LU0432979614.USD","LU0689472784.USD","SG9999001176.USD","LU0390134368.USD","LU2106854487.HKD","BMED","BK4585","IE00BQXX3F31.USD","LU0289739343.SGD","LU1551013342.USD","SG9999004303.SGD","LU1267930730.SGD","WDNA","LU0289961442.SGD","LU1974910355.USD","IDNA","GNOM","LU2063271972.USD","DHR","FMED","LU2355687059.USD","DTEC","ARKG","NBDS","KOMP","LU0528227936.USD","FWD","LU2125910336.SGD","LU1804176565.USD","LU1551013425.SGD","LU1791710582.SGD","SGXZ57979304.SGD","LU0820561818.USD","LU2211814178.USD","LU0943347566.SGD","LU0289960550.SGD","HELX","LU0882574055.USD","IE00BQXX3C00.GBP","IE0004445239.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667629489","title":"Illumina Inc(ILMN)股票9月15日盤中上漲7.40%:關鍵驅動因素揭曉","url":"https://stock-news.laohu8.com/highlight/detail?id=2667629489","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667629489?lang=zh_tw&edition=fundamental","pubTime":"2026-09-16 01:16","pubTimestamp":1789492606,"startTime":"0","endTime":"0","summary":"• 瑞银将 Illumina 评级上调至“买入”,目标价为 260 美元。\n• Illumina 将从标普中盘 400 指数重返标普 500 指数。\n• 公司报告 NovaSeq X 需求强劲,且业绩连续超出预期。","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262169279-market-movers-ilmn-20260915","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","GNOM","GNMX","LU0128526141.USD","ILMN","BK4588","BK4121","ILMNV","LU0029874061.USD","BK4534","BK4535","BK4548"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103100254","title":"Guardant Health與Evernorth旗下Evicore達成協議,Shield血液檢測自2027年1月1日起納入結直腸癌篩查覆蓋範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=1103100254","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103100254?lang=zh_tw&edition=fundamental","pubTime":"2026-09-15 04:08","pubTimestamp":1789416490,"startTime":"0","endTime":"0","summary":"Guardant Health公司宣布,Evernorth旗下的Evicore已决定将其Shield血液检测纳入结直肠癌(CRC)筛查的承保范围。这项覆盖计划将于2027年1月1日正式生效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4535","BK4588","EKG","PTH","HELX","LFSC","GNOM","GNMX","LU0320765992.SGD","BK4585","LU0889565916.HKD","GH","LU0109394709.USD","GDOC","BK4196","FFOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666571008","title":"阿斯利康股價盤後跌超2%,因其三期臨床試驗結果令人失望。","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571008","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571008?lang=zh_tw&edition=fundamental","pubTime":"2026-09-12 04:23","pubTimestamp":1789158183,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GNOM","SYNB","LU2322448791.USD","TMED","LFSC","HELX","LU1992135399.USD","PBE","BK4585","FTXH","BBH","CANC","LU2272731600.USD","LU2272731865.HKD","RSPH","PSCH","IBB","IDNA","IEIH","MRNY","XBIX","BK4588","FBT","BME","RXL","AZNH","LU2322448957.HKD","PJP","XPH","IEHS","LU2272731782.SGD","WDNA","IBRN","BIOY","LU2473716301.USD","IYH","MEDI","IE00B5TLWC47.USD","BBP","MRNX","LU1992135472.HKD","BIB","PPH","PBPH","SBIO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":48,"pageCount":1,"totalSize":192,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/GNOM\",params:#limit:6,delay:false,,,undefined,":[]}}